Best-effort research profile: this record has not passed full two-source scientific verification. Descriptive fields, research protocols, storage/handling notes, and interaction guidance below are shown with their evidence labels, but calculator presets and exact dosing math remain hidden until the record is verified or reaches Community-Supported status.
Quick Facts
Reference Sizes
500 mg tablet, 850 mg tablet, 1000 mg tablet, 1 g RUO powder, 10 g RUO powder
Storage
Store labeled tablets at controlled room temperature and protect from moisture; RUO powder requires lot-specific documentation
Solubility
Highly water-soluble as HCl salt
Best-Effort Research Profile
Metformin is an FDA-approved biguanide used with diet and exercise to improve glycemic control in type 2 diabetes. It lowers hepatic glucose production, reduces intestinal glucose absorption, and improves insulin sensitivity. Aging and longevity uses, including the proposed TAME program, remain investigational and do not create an approved anti-aging indication.
Source review pending. This descriptive profile is shown from the available source material as a best-effort educational reference. It has not passed the full verification bar and is not a dosing instruction, medical claim, or treatment recommendation.
Research Profile
Half-Life
~6.2 hours
Onset
Glycemic effects within days to weeks; TAME trial designed as a multi-year longevity-outcomes study
Administration Routes (Research)
Oral
Reported Research Effects
Reduces hepatic glucose production
Reduces intestinal glucose absorption
Improves insulin sensitivity
Investigational aging research is not an approved indication
Reported Research Side Effects
Diarrhea
Nausea and vomiting
Flatulence
Abdominal discomfort
Vitamin B12 reduction with longer use
Rare but serious lactic acidosis
Data source: Primary literature, regulator records, trial registries, and identity-specific evidence search
Reflects preclinical/research literature context only. Not a medical claim, dosing instruction, or treatment recommendation.
Route-Specific Research Protocols
Amounts and schedules are separated by administration route. Evidence badges distinguish labels, human studies, preclinical work, community reports, and evidence gaps.
Label / guidelineHuman studyCommunity onlyPreclinical onlyNot established
OralPreclinical only
Start 500 mg once or twice daily with meals and titrate to the selected product's labeled maximum
Frequency / timing
Daily in divided doses
Duration / setting
Ongoing with renal monitoring
Technique
Oral
Evidence
Preclinical / laboratory study
Context: current U.S. metformin labeling
Formulation: Oral-mucosal formulations are not dose-equivalent to injectable or topical formulations.
Route safety: Non-human or laboratory exposure. It cannot be converted into a human dose.
Do not convert an amount between routes. Bioavailability, formulation, sterility, monitoring, and clinical context differ by route. Research-use context only; independently verify every cited source.
Research Interactions
Flagged Avoid / Caution Combinations (Research)
eGFR below 30 mL/min/1.73 m2
Acute or chronic metabolic acidosis
Iodinated contrast without label-directed interruption assessment
Excessive alcohol use
Reflects patterns reported in research/community literature only. Not a safety guarantee, medical advice, or interaction warning for human use.
Research Notes
Prescription dosing is formulation- and renal-function-specific. The TAME aging trial is investigational and does not create an approved anti-aging indication.
Supplementary research context only. Not medical advice or a treatment recommendation.
Found a relevant Reddit or forum thread about this compound? Suggest it below. Every suggestion is reviewed by an editor before it appears -- nothing is published automatically.
Related Research Articles
Published articles on this site that mention Metformin or one of its catalog aliases.
Research Use Only. All content is for educational and research reference only. Not medical advice, a treatment recommendation, or guidance on human use. Compounds are not FDA-approved drugs unless specifically noted.